Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Phio Pharmaceuticals Corp. (PHIO)

Compare
1.2100
-0.0200
(-1.63%)
At close: 4:00:00 PM EDT
1.2212
+0.01
+(0.93%)
After hours: 5:16:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,486
10,698
11,462
13,511
8,793
Operating Income
-7,486
-10,698
-11,462
-13,511
-8,793
Net Non Operating Interest Income Expense
--
--
--
-9
-1
Other Income Expense
67
-128
-18
224
-1
Pretax Income
-7,419
-10,826
-11,480
-13,287
-8,794
Net Income Common Stockholders
-7,419
-10,826
-11,480
-13,287
-8,794
Diluted NI Available to Com Stockholders
-7,419
-10,826
-11,480
-13,287
-8,794
Basic EPS
-9.75
-46.80
-90.86
-112.32
-207.36
Diluted EPS
-9.75
-46.80
-90.86
-112.32
-207.36
Basic Average Shares
586.7430
231.5070
126.3350
118.8030
42.4750
Diluted Average Shares
586.7430
231.5070
126.3350
118.8030
42.4750
Total Operating Income as Reported
-7,612
-10,824
-11,462
-13,511
-8,793
Total Expenses
7,486
10,698
11,462
13,511
8,793
Net Income from Continuing & Discontinued Operation
-7,419
-10,826
-11,480
-13,287
-8,794
Normalized Income
-7,293
-10,700
-11,480
-13,287
-8,794
Net Interest Income
--
--
--
-9
-1
EBIT
-7,486
-10,698
-11,462
-13,511
-8,793
EBITDA
-7,408
-10,514
-11,269
-13,319
-8,721
Reconciled Depreciation
78
184
193
192
72
Net Income from Continuing Operation Net Minority Interest
-7,419
-10,826
-11,480
-13,287
-8,794
Total Unusual Items Excluding Goodwill
-126
-126
--
233
--
Total Unusual Items
-126
-126
--
233
--
Normalized EBITDA
-7,282
-10,388
-11,269
-13,319
-8,721
12/31/2020 - 5/10/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HOTH Hoth Therapeutics, Inc.
0.9784
+0.38%
 
SLRX Salarius Pharmaceuticals, Inc.
0.7265
+2.48%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.3100
+3.15%
 
REVB Revelation Biosciences, Inc.
2.6700
+1.52%
 
SLXN Silexion Therapeutics Corp
0.9920
-4.62%
 
SILO Silo Pharma, Inc.
1.0800
-4.42%
 
BDRX Biodexa Pharmaceuticals Plc
1.5400
+28.33%
 
KAPA Kairos Pharma, Ltd.
0.9185
-0.16%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5873
-0.03%
 
TVGN Tevogen Bio Holdings Inc.
1.0700
-1.83%